| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 06/12/2008 | US20080139576 5-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives |
| 06/12/2008 | US20080139565 Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular Dyslipidaemia |
| 06/12/2008 | US20080139558 Quinolones useful as inducible nitric oxide synthase inhibitors |
| 06/12/2008 | US20080139547 N-Hydroxyalkynylbenzamide (or hydroxamate) derivatives; anticarcinogenic and antiproliferative agents |
| 06/12/2008 | CA2669829A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2669819A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2669590A1 2-aminoquinolines as 5-ht(5a) receptor antagonists |
| 06/12/2008 | CA2668558A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2668520A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2668517A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2668515A1 Antibacterial quinoline derivatives |
| 06/12/2008 | CA2668512A1 Fumarate salt of (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
| 06/12/2008 | CA2667209A1 Improved linkers for anchoring targeting ligands |
| 06/11/2008 | EP1928856A1 Quinoline compounds capable of binding the cb2 and/or the 5-ht6 receptor |
| 06/11/2008 | EP1928835A1 Alkyl sulfoxide quinolines as nk-3 receptor ligands |
| 06/11/2008 | EP1928834A1 Alkylnitrile quinolines, as nk-3 receptor ligands |
| 06/11/2008 | EP1928833A1 Novel quinoline compounds capable of binding at the cb2 receptor |
| 06/11/2008 | EP1928832A1 Novel chemical process for the synthesis of quinoline compounds |
| 06/11/2008 | EP1601656A4 Tetrahydroquinoline derivatives useful as serine protease inhibitors |
| 06/11/2008 | EP1497266B1 Quinoline derivatives and their use as 5-ht6 ligands |
| 06/11/2008 | EP1230235B1 Compounds with antibacterial and antiparasitic properties |
| 06/11/2008 | CN101198613A Substituted tetrahydroquinoline |
| 06/11/2008 | CN101195614A Production of balofloxacin and purification process thereof |
| 06/11/2008 | CN101195603A Novel crystal system of pitavastatin calcium and method for producing the same |
| 06/11/2008 | CN101195597A 1-substituted-4,4-2 substituted thiosemicarbazide compounds, production method and uses of the same |
| 06/10/2008 | US7384973 Materials and methods for treating hypercholesterolemia |
| 06/10/2008 | US7384958 Quinoline inhibitors of cGMP phosphodiesterase |
| 06/10/2008 | US7384929 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof |
| 06/05/2008 | WO2008066097A1 Carboxylic acid derivative |
| 06/05/2008 | WO2008012782A3 Labelled analogues of halobenzamides as radiopharmaceuticals |
| 06/05/2008 | WO2007107246A3 SUBSTITUTED 2-AMINO-4-PHENYL-DιHYDROQUINOLINES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS MEDICAMENTS, AND MEDICAMENTS CONTAINING THEM |
| 06/05/2008 | US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors |
| 06/05/2008 | US20080132561 Materials and Methods for Treating Hypercholesterolemia |
| 06/05/2008 | US20080132507 Hydrazide Derivatives |
| 06/05/2008 | US20080132506 Anti-inflammatory medicaments |
| 06/05/2008 | US20080132496 Anticoagulants; factor Xa inhibitors; compounds are N-(benzimidazolyl, imidazo(4,5-b)pyridyl- or indolyl)-substituted benzamides |
| 06/05/2008 | CA2671080A1 Carboxylic acid derivatives |
| 06/04/2008 | EP1927589A1 Quinoline derivatives |
| 06/04/2008 | EP1927357A2 Low hygroscopic aripiprazole (crystal E) drug substance and processes for the preparation thereof |
| 06/04/2008 | EP1927356A1 Low hygroscopic aripiprazole (crystal D) drug substance and processes for the preparation thereof |
| 06/04/2008 | EP1927355A1 Low hygroscopic aripiprazole (crystal F) drug substance and processes for the preparation thereof |
| 06/04/2008 | EP1926711A1 Novel heterobicyclic derivatives useful as inhibitors of liver carnitine palmitoyl transferase |
| 06/04/2008 | CN101193862A Hydroxybenzamide derivatives and their use as inhibitors of HSP90 |
| 06/04/2008 | CN101193853A Anthranilic acid derivatives |
| 06/04/2008 | CN101190895A N-[(3S)-1,2,3,4-tetrahydroisoquinolino-3-formacyl]amino acid, preparation method and application thereof |
| 06/04/2008 | CN100392002C Polymers and oligomers, their synthesis, and electronic devices incorporating same |
| 06/03/2008 | US7381824 Quinoline derivatives |
| 06/03/2008 | US7381738 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity |
| 06/03/2008 | US7381566 Adding to sodium hydroxide and stirring; biosensors, nanoelectronics and transporting bioactive products |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 05/29/2008 | WO2008062770A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 05/29/2008 | WO2008062478A2 Improved process for pure montelukast sodium through pure intermediates as well as novel amine salts |
| 05/29/2008 | WO2008061900A1 Polymerisation of ethylene and alpha olefins with single site catalysts having an anionic scorpion-like ligand |
| 05/29/2008 | WO2008045673A3 Quinolone carboxylic acids, derivatives thereof, processes for its preparation and its use as antibacterial agents |
| 05/29/2008 | WO2007146072A3 Process for synthesizing piperazine-piperidine compounds |
| 05/29/2008 | US20080125594 Process and intermediates for preparing integrase inhibitors |
| 05/29/2008 | US20080125463 2-Bromo-N-[1-(7-chloro-quinolin-4-yl)-piperidin-4-yl]-benzamide; fertility disorders, menstrual pains, endometriosis, pain, cancer, osteoporosis |
| 05/29/2008 | US20080125462 Cinnamate Salts Of A Beta-2 Adrenergic Agonist |
| 05/29/2008 | US20080125424 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 05/29/2008 | US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 05/28/2008 | EP1925620A1 Polymerisation of ethylene and alpha olefins with single site catalysts having an anionic scorpion-like ligand |
| 05/28/2008 | EP1925308A1 Low hygroscopic aripiprazole (crystal G) drug substance and processes for the preparation thereof |
| 05/28/2008 | EP1924551A2 Organic compounds |
| 05/28/2008 | CN101189211A Quinoline derivatives as NK3 anatgonists |
| 05/28/2008 | CN101189208A 3-methanesulfonylquinolines as GABA-B enhancers |
| 05/28/2008 | CN101186605A 2-vinyl-8-hydroxyquinoline derivative, preparation method and application thereof |
| 05/28/2008 | CN101186549A Method for preparing amino acid by reducing ketoxime acid ester |
| 05/28/2008 | CN100390155C Quinoline and quinoxaline compounds |
| 05/28/2008 | CN100390154C Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 05/28/2008 | CN100390148C Method for the treatment of malignant tumours |
| 05/27/2008 | US7378524 e.g., 6-chloro-2-methyl-4-(N-(2-(N-(p-methoxyphenylsulfonyl)-N-(2-(2,5-dimethoxy-4-nitroanilinocarbonyl)ethyl)amino)ethyl)amino)quinoline; used to treat inflammatory and immune diseases by binding to CXCR3 receptors. |
| 05/27/2008 | US7378523 Quinolinols as fluxing and accelerating agents for underfill compositions |
| 05/27/2008 | US7378522 Such as 6-(4-Acetamidophenoxy)-5-(N-benzyl-N-methylaminomethyl)-1-(2',6'-difluorobenzyl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid-ethyl ester; rapid effectiveness, bioavailability; low cost, simple synthesis |
| 05/27/2008 | US7378430 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 05/27/2008 | US7378162 Dopant iridium complexes of 2-alkylphenylquinolines and an alkanedione; host compounds are aluminum or zinc complexes with phenyl, biphenyl, or (iso)quinolinyl ligands or carbazole-biphenyl (CBP); high color purity, high brightness, and long durability; flat panel displays |
| 05/27/2008 | US7378161 Organometallic complexes and organic electroluminescence device using the same |
| 05/22/2008 | WO2008060283A1 4-anilino-3-quinolinecarbonitriles for the treatment of acute myelogenous leukemia (aml) |
| 05/22/2008 | WO2008060269A2 Quinoline methanol compounds for the treatment and prevention of parasitic infections |
| 05/22/2008 | WO2008059867A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059866A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059865A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059513A2 Compounds suitable as modulators of hdl |
| 05/22/2008 | WO2008059128A1 Phenylic derivatives and use thereof as drugs |
| 05/22/2008 | WO2008059051A1 Synthesis of imide compounds |
| 05/22/2008 | WO2008058536A1 Novel 4-amino-pyridine derivatives and their use as potassium channel modulators |
| 05/22/2008 | WO2008033836A3 Process and intermediates for preparing integrase inhibitors |
| 05/22/2008 | WO2008029282A3 Aqueous formulation comprising an antitumor agent |
| 05/22/2008 | US20080119652 A crystalline form X, Y, Z of Gatifloxacindissolving gatifloxacin in methanol, removing insoluble, adding a base ( triethylamine or diisopropylethylamine), maintaining the reaction mixture at an appropriate temperature, cooling, isolating and drying; bactericides |
| 05/22/2008 | US20080119516 2-'4(Phenylamino)-Piperidin-1-Yl!-N-Phenyl-Acetamine Derivatives and Related Compounds as Neuropeptide Y5 (NPY5) Ligands for the Treatment of Obesity |
| 05/22/2008 | US20080119515 Heterocyclic Kinase Inhibitors: Methods of Use and Synthesis |
| 05/22/2008 | US20080119514 6-(2,4-dinitrophenylazo)-2,5,7,8-tetramethyltridecyl))-1,2,3,4-tetrahydroquinoline; to treat cell proliferative diseases |
| 05/22/2008 | US20080119513 To treat osteoarthritis; matrix metalloproteinases-13 inhibitors |
| 05/22/2008 | US20080119478 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria |
| 05/22/2008 | US20080119453 Bicyclic derivatives as modulators of ion channels |
| 05/22/2008 | CA2669607A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2668596A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2668592A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/21/2008 | EP1922135A1 Hindered cyclic polyamines and their salts for acid gas scrubbing process |
| 05/21/2008 | EP1812395B1 Method for the preparation of aripiprazole, and corresponding intermediates and their preparation |
| 05/21/2008 | EP1482924B1 Cathepsin cysteine protease inhibitors |